# FDA Inspection 660516 - Artur Racewicz, MD, PhD - April 16, 2010

Source: https://www.keypedia.com/records/fda_inspections/artur-racewicz-md-phd/60377ee3-d881-4e3e-8a2b-c3175f5410fe
Source feed: FDA_Inspections

> FDA Inspection 660516 for Artur Racewicz, MD, PhD on April 16, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 660516
- Company Name: Artur Racewicz, MD, PhD
- Inspection Date: 2010-04-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1247218 - 2024-08-22](https://www.keypedia.com/records/fda_inspections/artur-racewicz-md-phd/9363fc4e-078e-48b6-b901-65f6fc5ec2f2)
- [FDA Inspection 968637 - 2016-05-12](https://www.keypedia.com/records/fda_inspections/artur-racewicz-md-phd/bb361ce8-87d4-4763-827c-16c4458f4101)
- [FDA Inspection 784784 - 2012-04-27](https://www.keypedia.com/records/fda_inspections/artur-racewicz-md-phd/6a1b1652-7bdd-4c58-91a4-9edfb20df870)

Company: https://www.keypedia.com/companies/artur-racewicz-md-phd/b6054036-5318-49f0-a535-d51b25f678a6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c